ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 653

Reduced Ubiquitination of Misfolded HLA-B27 Is Associated with Inefficient Degradation By ERAD and Autophagy

Fatemeh Navid1, Gerlinde Layh-Schmitt1, Keith A. Sikora2 and Robert Colbert1, 1National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 2Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: autophagy and spondylarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Spondyloarthropathies and Psoriatic Arthritis – Pathogenesis, Etiology Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

The HLA class I allele, HLA-B27, is associated with spondyloarthritis (SpA), an immune-mediated inflammatory disease affecting the axial skeletal, skin, gut and eyes. HLA-B27 has a tendency to misfold, and accumulate in the endoplasmic reticulum (ER) and on the cell surface as disulfide-linked dimers. ER accumulation can generate stress resulting in an unfolded protein response (UPR). The UPR upregulates several pathways that promote folding and secretion and/or ER-associated degradation (ERAD) of accumulated proteins, which involves retrotranslocation and ubiquitination of target proteins in the cytosol where they are degraded by proteasomes. Our recent studies suggest that autophagy as well as ERAD contributes to the disposal of misfolded HLA-B27, yet these pathways are still not sufficient to prevent misfolded HLA-B27 from accumulating. Since these pathways of protein degradation require substrate ubiquitination, we asked whether HLA-B27 heavy chains were ubiquitinated using HLA-B7 for comparison.

Methods: Bone marrow derived macrophages from HLA-B27 and human β2m (hβ2m) transgenic rats were examined with and without IFNγ and proteasome or autophagy inhibitors. Immunoprecipitation, western blotting, and immunofluorescence were used to measure HLA-B27 heavy chains and ubiquitination mount. Autophagy was activated using rapamycin, or blocked with bafilomycin. ERAD was inhibited by inhibiting proteasome function with bortezomib. HLA-B7/hβ2m transgenic rat macrophages were used as controls.

Results: Blocking autophagic flux with bafilomycin resulted in the accumulation of misfolded HLA-B27 dimers and oligomers as well as monomers, comparable to blocking ERAD with the proteasome inhibitor bortezomib. HLA-B7 monomers also accumulated after blocking each degradation pathway. The proportion of ubiquitinated heavy chains was ~3-fold lower for HLA-B27 compared to HLA-B7. Immunoprecipitation experiments using anti-ubiquitin antibody followed by blotting for HLA class I heavy chains, further confirmed that HLA-B7 is significantly more ubiquitinated than HLA-B27. Activation of autophagy with rapamycin rapidly eliminated ~50% of misfolded HLA-B27, while folded HLA-B27 or HLA-B7 monomeric heavy chains were minimally affected.

Conclusion: These results demonstrate for the first time that both autophagy and ERAD play a role in the elimination of excess HLA class I heavy chains expressed in transgenic rats. Our results suggest that impaired ubiquitination of HLA-B27 may play a role in the accumulation of misfolded disulfide-linked dimers, whose elimination can be enhanced by activation of autophagy. Manipulation of the autophagy pathway should be further investigated as a potential therapeutic avenue in experimental spondyloarthritis.


Disclosure: F. Navid, None; G. Layh-Schmitt, None; K. A. Sikora, None; R. Colbert, None.

To cite this abstract in AMA style:

Navid F, Layh-Schmitt G, Sikora KA, Colbert R. Reduced Ubiquitination of Misfolded HLA-B27 Is Associated with Inefficient Degradation By ERAD and Autophagy [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/reduced-ubiquitination-of-misfolded-hla-b27-is-associated-with-inefficient-degradation-by-erad-and-autophagy/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reduced-ubiquitination-of-misfolded-hla-b27-is-associated-with-inefficient-degradation-by-erad-and-autophagy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology